TLR2 and lung carcinoma: Taken together, these results suggest that propionate inhibited TLR2- or TLR3-induced lung cancer progression by inhibiting the AMPK-TAK1 signaling axis to activate NF-κB inhibition, as depicted in Fig. 5J.